Anti-cancer CAR-T therapy reengineers T cells to kill tumors – and researchers are expanding the limited types of cancer it can target
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.)
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.)